Skip to main content
. 2021 Jul 9;11:14205. doi: 10.1038/s41598-021-93255-z

Table 1.

Description of the commercial studied extracts.

Commercial names Pharmaceutical forms: doses (in mg/mL) (studied form in bold) Type of extract Abbreviation used
AbnobaVISCUM: Aceris, Amygdali, Betulae, Crataegi, Fraxini, Mali, Pini, Quercus Injectable solution: 0.02, 0.2, 2, 20 Unfermented fresh juice Aac, Aam, Ab, Ac, Af, Am, Ap, Aq
Helixor A (Abietis), Helixor M (Mali), Helixor P (Pini) Injectable solution: 0.01, 0.1, 1, 5, 10, 20, 30, 50 Aqueous unfermented extract from fresh juice herb (1:20) Hab, Hm, Hp
Iscador A (Abietis), Iscador M (Mali), Iscador P (Pini) Injectable solution: 0.0001, 0.001, 0.01, 0.1, 1, 10, 20 Aqueous extract from fresh juice herb + fermentation Iab, Im, Ip
Weleda M (Mali), Weleda P (Pini), Weleda Q (Quercus) Injectable solution: 0.0001, 0.001, 0.01, 0.1, 1, 10, 20 Aqueous extract from fresh juice herb + fermentation Wm, Wp, Wq

For the abbreviation, the first capital letter corresponds to the company name and the lowercase letters indicate the host tree (ab: abietis, ac: aceris, am: amygdali, b: betulae, c: crataegi, f: fraxini, m: mali, p: pini, q: quercus).